Management of Chemotherapy-Induced Acute Kidney Injury

Introduction to Chemotherapy-Induced Acute Kidney Injury

The American College of Physicians recommends that dialysis initiation in patients with chemotherapy-induced acute kidney injury should be driven by clinical indications, such as uremic symptoms, refractory volume overload, severe metabolic derangements, or malnutrition, rather than by GFR alone 1

The National Kidney Foundation suggests obtaining measured GFR using 24-hour urine collection for creatinine and urea clearance, rather than relying on estimated GFR, to confirm true renal function in patients with chemotherapy-induced acute kidney injury 2, 3

The American Society of Nephrology recommends that conservative management should continue until GFR <15 mL/min/1.73 m², unless specific clinical indications mandate earlier initiation of dialysis 3, 1
The American College of Cardiology recommends that uremic symptoms, such as pericarditis, encephalopathy, intractable nausea/vomiting, and bleeding diathesis, are absolute indications for dialysis initiation in patients with chemotherapy-induced acute kidney injury 4, 1
The European Renal Association recommends that volume overload refractory to diuretic therapy is an absolute indication for dialysis initiation in patients with chemotherapy-induced acute kidney injury 1, 5
The American Heart Association recommends that uncontrolled hypertension despite maximal medical management is an absolute indication for dialysis initiation in patients with chemotherapy-induced acute kidney injury 1
The National Institute of Diabetes and Digestive and Kidney Diseases recommends that severe metabolic derangements, such as hyperkalemia unresponsive to medical therapy and severe metabolic acidosis, are absolute indications for dialysis initiation in patients with chemotherapy-induced acute kidney injury 1
The American Society for Nutrition recommends that protein-energy malnutrition that develops or persists despite vigorous nutritional intervention is an absolute indication for dialysis initiation in patients with chemotherapy-induced acute kidney injury 6, 1

The American Society of Nephrology recommends that the first dialysis treatment should use a "low and slow" approach to minimize dialysis disequilibrium syndrome and hemodynamic instability in patients with chemotherapy-induced acute kidney injury 1, 7
The European Renal Association recommends that the initial session duration should be 2-2.5 hours, with reduced blood flow rates of 200-250 mL/min, and minimal ultrafiltration during the first session 1, 7
The American College of Physicians recommends that frequent vital sign monitoring should be performed every 15-30 minutes during the first dialysis session, with close observation for neurological symptoms indicating dialysis disequilibrium 7
The National Kidney Foundation recommends that gradual dose escalation should be performed over subsequent sessions as tolerated in patients with chemotherapy-induced acute kidney injury 1, 7

The American Society of Nephrology recommends that dialysis should not be initiated based on GFR alone, as early dialysis initiation in asymptomatic patients provides no survival benefit and may cause harm 1
The American Heart Association recommends that hemodialysis-related hypotension may accelerate loss of residual kidney function, which is particularly problematic in chemotherapy patients who may recover renal function 2, 3, 5
The European Renal Association recommends that dialysis does not replace all kidney functions and imposes significant burden on patients already dealing with cancer treatment 3, 1
The American College of Cardiology recommends that aggressive first dialysis sessions should be avoided, as rapid removal of uremic toxins can cause cerebral edema, seizures, and cardiovascular instability 7